Sep 25, 2025
Supporting Market Entry and Regulatory Success in Saudi Arabia
On September 25, 2025, IPDataLab, in collaboration with Pi Pharma Intelligence, successfully hosted a webinar titled “Navigating the Saudi Market: Insights into Incentives and New Regulatory Frameworks”.
The session brought together over 100 participants, primarily regulatory affairs managers from various Chinese pharmaceutical companies, reflecting the strong and growing interest in opportunities within Saudi Arabia and the broader Middle East.
The webinar provided a comprehensive overview of the regional market landscape, with a particular focus on Saudi Arabia. Topics discussed included:
Recent regulatory frameworks and key requirements for market entry;
Incentives and opportunities for international pharmaceutical companies;
Balancing accessibility and affordability in the Saudi healthcare system;
Drug pricing policies and their implications for market strategy.
Speakers included Hazem Al-Yacoub, Abeer Khriesha, and Miao Li, who shared practical experiences and insights. The session was highly appreciated by attendees for its comprehensiveness, clarity, and depth, offering concrete guidance for pharmaceutical companies considering entry into the Saudi market.
As part of IPDataLab’s mission to support Chinese pharmaceutical companies in their global expansion, we are pleased to make the presentation slides available for download.